Lv3
370 积分 2026-02-04 加入
LRRC15-CAR T cells for the treatment of osteosarcoma
4个月前
已完结
Measuring T-cell/CAR T-cell bystander tumor killing in vitro and in vivo
4个月前
已完结
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
4个月前
已完结
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
4个月前
已完结
The dawn of in vivo immune cell engineering in oncology
4个月前
已完结
Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity
4个月前
已完结
Single-Chain IL-23 Secretion by CAR T Cells Improves Tumor Control and Persistence Against Solid Tumors
4个月前
已完结
Clinical Trial Results Provide the Rationale to Protect Dual HIV-specific T Cells with a Signaling-Defective HIV Fusion Inhibitor
4个月前
已完结
Enhancing Adoptive T Cell Therapy by Disrupting the SKI-SMAD2/3 Axis to Counteract TGF-β-Mediated Immunosuppression
4个月前
已关闭
CD96 as a therapeutic target for CAR T cell therapy in acute myeloid leukemia
4个月前
已完结
皖公网安备34019202002308
